Chan Gerald 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 4, 2021
Insider Transaction Report
Form 4
Chan Gerald
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-01-01+27,600→ 27,600 totalExercise: $57.20Exp: 2030-12-31→ Common Stock (27,600 underlying)
Footnotes (1)
- [F1]This option was granted 01/01/2021. The option vests quarterly over 1 year on the last day of each quarter from grant date